about
Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitisFunctional Intestinal Bile Acid 7α-Dehydroxylation by Clostridium scindens Associated with Protection from Clostridium difficile Infection in a Gnotobiotic Mouse ModelDestruction of lymphoid organ architecture and hepatitis caused by CD4+ T cells.Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling.CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progressionIL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasmsCytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ.Dendritic cell-based immunotherapy for myeloid leukemias.TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance.From "magic bullets" to specific cancer immunotherapy.Regulation of hematopoietic and leukemic stem cells by the immune system.Innate immunity restricts Citrobacter rodentium A/E pathogenesis initiation to an early window of opportunity.Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling.CD27 signaling increases the frequency of regulatory T cells and promotes tumor growth.Tumor Heterogeneity in Lymphomas: A Different Breed.Modulating CD27 signaling to treat cancer.Cytotoxic CD8+ T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells.CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemiaBlocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cellsInterferons in hematopoiesis and leukemia."Leiomyomatoid angiomatous neuroendocrine tumor" (LANT) of the pituitary reflects idiosyncratic angiogenesis in adenomas of the gonadotroph cell lineage.Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells.The "don't eat me" signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma.Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression.The Multi-kinase Inhibitor Debio 0617B Reduces Maintenance and Self-renewal of Primary Human AML CD34+ Stem/Progenitor Cells.How mechanisms explain interfield cooperation: biological-chemical study of plant growth hormones in Utrecht and Pasadena, 1930-1938.Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.CD47 protein expression in acute myeloid leukemia: A tissue microarray-based analysisChronic myelogenous leukemia maintains specific CD8+ T cells through IL-7 signalingTNIK signaling imprints CD8+ T cell memory formation early after primingA review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integrationCARving up colorectal cancer organoids in vitroTargeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic StrategyA Multiscale Map of the Stem Cell State in Pancreatic AdenocarcinomaUncoupling of invasive bacterial mucosal immunogenicity from pathogenicity
P50
Q28757559-11744625-E2D9-4724-B4C8-9A155B5EE75DQ28817073-EEAD1562-04B2-4152-BE67-4E08BD9BCFA5Q34037791-A15A02F5-CD73-4657-B16A-A981FDC7F363Q35322800-88DAA057-A021-428F-809B-A1D9B33ACF97Q35698863-F597A6E3-4891-4540-92AD-793027E194B9Q36040193-940ED95D-477D-4068-BD0C-46D03B7AF232Q36694195-D72A2AE3-FC7E-4AB4-A72C-59D88C0FA7B0Q37420778-31A8BFC3-CD99-4F68-B5B7-B039C3CE291BQ37488144-0AF9E9A5-D7F7-47A5-9DA0-85047AA078BCQ38076656-12679E5E-9D02-479D-B393-A21675271572Q38225994-5C5699DD-F015-4086-8BBF-3B8B6F2B5EB3Q38702344-EA7C87D9-6F31-45F1-91C4-DDDC3F39635DQ38848102-EA1832D5-247C-47C0-9F7A-EFB292CBDBD4Q39342390-822EF08B-5495-446A-8E64-A7A401133DB9Q39442269-4261E251-3D22-4B99-8A59-DEBEE32FA4A3Q41855840-80AE4DB4-3EBE-4A58-A6F0-EA6B49320189Q42235697-1C3FB4E9-D103-4549-8264-E78205256939Q42323497-A3569DAE-FF91-467B-9A61-54E8FC651075Q42428547-ACCB0795-44B9-47C8-9B2B-E55A7A68B7DCQ43084694-59AFC689-F321-44D9-A58C-F142456AB3FAQ43645208-788A184F-EF0C-45C1-8858-070BD7B1A7C4Q44582912-6571E655-3A09-4C06-9101-A500930E9A41Q47133389-DBAD146D-5717-4347-8B1C-CAB7684C8C9CQ47867798-E3086761-1A12-4643-8C75-FBA6A88D12A8Q53741533-AAEE4FF8-7A37-4CB4-ADF0-CEF9590913DEQ54244714-CF41CA2B-29E9-4613-B543-9A0FF6DB2C40Q55354182-B7E527B6-7ED0-45E1-B8EE-E77E05972685Q63968538-A9728275-532C-49D7-8A82-5B9AF0E263BEQ63968539-0F493AF3-C33B-4BE0-B75C-4E919A47FBABQ91522152-4EAF7995-5EC1-4AE4-8D1A-785CB820D2BCQ92061624-777B3055-FBA2-4515-ABD7-A0B30521209BQ92145056-4F38EDD9-434D-4A9F-B4D4-FB55DAB66722Q92779589-A80712F9-2EFC-4CA4-8E06-6AEF72DC6CFCQ92905126-6F75DB11-837F-445D-BCC7-0E7B3D8159DDQ93216398-B58B8E8D-5241-4BF2-9E65-F0AC12037DF8
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Christian Schürch
@ast
Christian Schürch
@en
Christian Schürch
@es
Christian Schürch
@sl
type
label
Christian Schürch
@ast
Christian Schürch
@en
Christian Schürch
@es
Christian Schürch
@sl
prefLabel
Christian Schürch
@ast
Christian Schürch
@en
Christian Schürch
@es
Christian Schürch
@sl
P106
P1153
26642210200
P21
P2798
P31
P3835
christian-schrch
P496
0000-0002-1792-1768